Factors Associated with Deaths in Hospitalized Cancer Patients and COVID-19 in an Amazon Region: a Cross-sectional Study with Data from Epidemiological Surveillance
Daniele Melo Sardinha, Rebecca Lobato Marinho, Juliane Lima Alencar, Marina Pereira Queiroz dos Santos, Rosane do Nascimento Rodrigues, Paulo Henrique Viana da Silva, Lucas Vinícius Moraes da Silva, Diana da Costa Lobato, Milena Farah Damous Castanho Ferreira, Natasha Cristina Oliveira Andrade, Tamires De Nazaré Soares, Juliana Conceição Dias Garcez, Ana Lúcia da Silva Ferreira
Asian Journal of Research in Infectious Diseases · pp. 1–9 · Published 5 Apr 2022
10.9734/ajrid/2022/v9i430273Abstract
Background: The COVID-19 pandemic has already affected Brazil dramatically, but the northern region of the country has suffered greater impacts due to regional vulnerability factors. Objective: To describe the factors associated with deaths in hospitalized cancer patients and COVID-19 in the state of Pará, Brazil. Methods: Cross-sectional study with data from epidemiological surveillance of acute and severe respiratory syndromes of hospitalized cases notified from January 1, 2020, to December 31, 2020. Clinical and outcome variables, chi-square test, and Odds ratio were analyzed. Results: 164 cases, lethality represented 94 (57.32%). The mean overall age was 63 years, of survivors was 60 years and of deaths was 66 years. Advanced age was associated with deaths (p-0.039). Male gender was associated with deaths (65.96% - p- 0.006 - OR 2,438 - CI 1,291-4,604). Similarly, the signs and symptoms associated with death were dyspnea (80.85% - p- 0.028 - OR 2,203 - CI 1,080-4,491), respiratory distress (76.60% - p- 0.003 - OR 2,756 - CI 1,410-5,387), O2 saturation <95% represented almost four times to the chances of death (68.09% - p-<0.001 - OR 3,398 - CI 1,798-6,494). Comorbidities were not associated with deaths, however, Immunodeficiency/Immunodepression represented the most frequent in the cases (22.56%), followed by Chronic Cardiovascular Disease (21.95%) and Diabetes Mellitus (18.90%). ICU admission was associated with deaths with the highest odds ratio of the analysis almost five times (42.55% - p- <0.001 - OR 4,444 - CI 2,028-9,739). Conclusion: In this study, we showed that the lethality was higher than in other studies of hospitalized cancer patients with COVID-19, as well as higher than the overall lethality of COVID-19 among hospitalized patients. The factors associated with deaths are similar to those in the literature, except that immunodeficiency is a specific condition in cancer patients and is associated with an unfavorable outcome.
Cited by 0
No indexed citations yet.
Related research
- Bizarre Retroperitoneal Fibromatosis: Challenges in Management — shares topic coverage
- Clinical and Therapeutic Approach to Lymphocytic Alimentary Lymphoma in a Cat: Case Report — shares topic coverage
- Mucoepidermoid Carcinoma of Hard Palate in a Pediatric Case — shares topic coverage
- Isolated XIITH Cranial Nerve Palsy Secondary to Diffuse Large B Cell Lymphoma – A Rare Occurrence — shares topic coverage
- Adenocarcinoma of Appendix Mimicking Acute Appendicitis — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.